| Product Code: ETC4877024 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Nuclear Medicine Radioisotopes Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 Ireland Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in nuclear medicine |
4.2.2 Increasing prevalence of cancer and other chronic diseases |
4.2.3 Growing awareness about the benefits of nuclear medicine in diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High initial setup costs and infrastructure requirements |
4.3.2 Stringent regulatory requirements and safety concerns associated with radioisotopes |
4.3.3 Limited availability of skilled professionals in the field of nuclear medicine |
5 Ireland Nuclear Medicine Radioisotopes Market Trends |
6 Ireland Nuclear Medicine Radioisotopes Market Segmentations |
6.1 Ireland Nuclear Medicine Radioisotopes Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2021-2031F |
6.1.3 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2021-2031F |
6.1.4 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2021-2031F |
6.1.5 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2021-2031F |
6.1.6 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2021-2031F |
6.1.7 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2021-2031F |
6.1.9 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.2 Ireland Nuclear Medicine Radioisotopes Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2021-2031F |
6.2.3 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2021-2031F |
6.2.4 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2021-2031F |
6.2.5 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2021-2031F |
6.2.6 Ireland Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
7 Ireland Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 Ireland Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 Ireland Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 Ireland Nuclear Medicine Radioisotopes Market Key Performance Indicators |
8.1 Number of new nuclear medicine facilities opened in Ireland |
8.2 Percentage increase in the adoption of nuclear medicine procedures |
8.3 Research and development investment in new radioisotope technologies |
9 Ireland Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 Ireland Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Ireland Nuclear Medicine Radioisotopes Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 Ireland Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2024 |
10.2 Ireland Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here